DD from sello on another board "Just to make it
Post# of 1425
(Total Views: 316)
Posted On: 03/03/2020 10:12:14 PM
DD from sello on another board
"Just to make it a little clearer. Here are the requirements from the EPA on the emerging virus claim.
Registrants should use the following criteria to determine if an EPA-registered disinfectant
product is eligible to use the process described in this Guidance. An eligible product should meet both of the following criteria:
1. The product is an EPA-registered, hospital/healthcare or broad-spectrum disinfectant with directions for use on hard, porous or non-porous surfaces2. (CHECK)
2. The currently accepted product label (from an EPA registered product as described
above in III.1) should have disinfectant efficacy claims against at least one of the following viral pathogen groupings:
a) A product should be approved by EPA to inactivate at least one large or one small non-enveloped virus to be eligible for use against an enveloped emerging viral pathogens. (AND CHECK)
b) A product should be approved by EPA to inactivate at least one small, nonenveloped virus to be eligible for use against a large, non-enveloped emerging viral pathogen.
c) A product should be approved by EPA to inactivate at least two small, nonenveloped viruses with each from a different viral family to be eligible for use against a small, non-enveloped emerging viral pathogen.
Here's the list of small non-enveloped
Small, Non-Enveloped Viruses (<50 nm): These small, non-enveloped viruses can be highly resistant to inactivation by disinfection. Despite the lack of a lipid envelope, these organisms have a very resistant protein capsid. The following are viral families in the small non-enveloped subgroup: (1) Picornaviridae, (2) Parvoviridae, (3) Caliciviridae, (4) Astroviridae, and (5) Polyomaviridae.
https://www.epa.gov/sites/production/files/20..._001_0.pdf
and here is PCT's registration.
https://www3.epa.gov/pesticides/chem_search/p...171012.pdf
Under non enveloped, calicvirus. For those you may think Calicvirus and Caliciviridae are different...
Description of Pathogens
Caliciviruses were discovered in 1972 by electron microscopy of stool samples from children affected by an outbreak of gastroenteritis in a school in Norwalk, Ohio, several years previously.1 This discovery of the subsequently named Norwalk virus marked the first identification of a virus as a cause of gastroenteritis. Named for the marked cup-like depressions in the capsid (calyx = cup in Latin) (Figure 239-1), the family Caliciviridae are small, nonenveloped single-stranded RNA viruses divided into five genera: Norovirus, Sapovirus, Lagovirus, Vesivirus, and the recently added Nebovirus.2,3 Noroviruses and sapoviruses include human pathogens, with main characteristics shown in Table 239-1. Lagoviruses, vesiviruses, and neboviruses are animal pathogens and have not been detected in naturally occurring human illnesses.
https://www.sciencedirect.com/topics/medicine...iciviridae
"
"Just to make it a little clearer. Here are the requirements from the EPA on the emerging virus claim.
Registrants should use the following criteria to determine if an EPA-registered disinfectant
product is eligible to use the process described in this Guidance. An eligible product should meet both of the following criteria:
1. The product is an EPA-registered, hospital/healthcare or broad-spectrum disinfectant with directions for use on hard, porous or non-porous surfaces2. (CHECK)
2. The currently accepted product label (from an EPA registered product as described
above in III.1) should have disinfectant efficacy claims against at least one of the following viral pathogen groupings:
a) A product should be approved by EPA to inactivate at least one large or one small non-enveloped virus to be eligible for use against an enveloped emerging viral pathogens. (AND CHECK)
b) A product should be approved by EPA to inactivate at least one small, nonenveloped virus to be eligible for use against a large, non-enveloped emerging viral pathogen.
c) A product should be approved by EPA to inactivate at least two small, nonenveloped viruses with each from a different viral family to be eligible for use against a small, non-enveloped emerging viral pathogen.
Here's the list of small non-enveloped
Small, Non-Enveloped Viruses (<50 nm): These small, non-enveloped viruses can be highly resistant to inactivation by disinfection. Despite the lack of a lipid envelope, these organisms have a very resistant protein capsid. The following are viral families in the small non-enveloped subgroup: (1) Picornaviridae, (2) Parvoviridae, (3) Caliciviridae, (4) Astroviridae, and (5) Polyomaviridae.
https://www.epa.gov/sites/production/files/20..._001_0.pdf
and here is PCT's registration.
https://www3.epa.gov/pesticides/chem_search/p...171012.pdf
Under non enveloped, calicvirus. For those you may think Calicvirus and Caliciviridae are different...
Description of Pathogens
Caliciviruses were discovered in 1972 by electron microscopy of stool samples from children affected by an outbreak of gastroenteritis in a school in Norwalk, Ohio, several years previously.1 This discovery of the subsequently named Norwalk virus marked the first identification of a virus as a cause of gastroenteritis. Named for the marked cup-like depressions in the capsid (calyx = cup in Latin) (Figure 239-1), the family Caliciviridae are small, nonenveloped single-stranded RNA viruses divided into five genera: Norovirus, Sapovirus, Lagovirus, Vesivirus, and the recently added Nebovirus.2,3 Noroviruses and sapoviruses include human pathogens, with main characteristics shown in Table 239-1. Lagoviruses, vesiviruses, and neboviruses are animal pathogens and have not been detected in naturally occurring human illnesses.
https://www.sciencedirect.com/topics/medicine...iciviridae
"
(0)
(0)PCT Ltd. (PCTL) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.